Role of water in the physical stability of solid dosage formulations

被引:85
|
作者
Airaksinen, S [1 ]
Karjalainen, M
Shevchenko, A
Westermarck, S
Leppänen, E
Rantanen, J
Yliruusi, J
机构
[1] Univ Helsinki, Fac Pharm, Pahrmaceut Technol Div, FIN-00014 Helsinki, Finland
[2] Orion Pharma, Espoo, Finland
[3] Univ Helsinki, Viikki FDrug Discovery Technol Ctr, DDTC, FIN-00014 Helsinki, Finland
关键词
dynamic vapor sorption; excipients; near-infrared (NIR) spectroscopy; phase transition; sorption isotherms; X-ray powder diffraction;
D O I
10.1002/jps.20411
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interaction of moisture with pharmaceutical solids is highly crucial to an understanding of water-based processes, for example, manufacturing processes or prediction of solid dosage form stability and shelf life. Both the active pharmaceutical ingredient (API) and excipients in the formulation have different moisture sorption properties that can result in unexpected processing-induced phase transitions and they can affect solid-state phase transitions in the final dosage forms. The character of excipient effects on the stability of formulation. Phase transformations in formulations can lead to instability in physicochemical, biopharmaceutical, and processing properties of products. The aim of the present study was to investigate the water sorption properties of different excipients, model the sorption isotherms, examine the phase transitions, and identify differences of excipients in solid dosage form stability using dynamic vapor sorption analysis, near-infrared spectroscopy, and X-ray diffraction methods. The thermal processing was carried out with a variable temperature X-ray powder diffractometer to compare the dehydration behavior of wet excipients and evaluate solid-state properties during heating. These results showed that despite some limitations, moisture sorption isotherms of excipients are useful in predicting solid-state stability, interactions at early stages of formulation development, and effects of moisture on physicochemical properties of the final dosage forms. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:2147 / 2165
页数:19
相关论文
共 50 条
  • [11] Thermodynamic stability of solid pharmaceutical formulations
    Sridhar, LN
    Ramirez-Beltran, ND
    Rodriguez, H
    CHEMICAL ENGINEERING COMMUNICATIONS, 2001, 185 (185) : 59 - 66
  • [12] PHARMACOKINETICS AND BIOAVAILABILITY OF CONTROLLED RELEASE SOLID DOSAGE CARBAMAZEPINE FORMULATIONS
    Vlase, L.
    Tomuta, I
    Popa, A.
    Muntean, D.
    Leucuta, S. E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 108 - 108
  • [13] Stability of dry coated solid dosage forms
    Kablitz, Caroline Desiree
    Urbanetz, Nora Anne
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2009, 14 (06) : 613 - 622
  • [14] STABILITY STUDIES OF SMALL SOLID DOSAGE FORMS
    KORNBLUM, SS
    DRUG & COSMETIC INDUSTRY, 1970, 106 (04): : 42 - &
  • [15] EFFECT OF MOISTURE ON THE STABILITY OF SOLID DOSAGE FORMS
    CARSTENSEN, JT
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (14) : 1927 - 1969
  • [16] Physical stability of dry powder inhaler formulations
    Shetty, Nivedita
    Cipolla, David
    Park, Heejun
    Zhou, Qi Tony
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (01) : 77 - 96
  • [17] Addressing physical stability of complex suspension formulations
    Zhang, Junhua
    Klopf, Gary
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [18] Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans
    Chimalakonda, Anjaneya
    Li, Wenying
    Marchisin, David
    He, Bing
    Singhal, Shalabh
    Deshpande, Prashant
    Brown, Jonathan
    Aras, Urvi
    Murthy, Bindu
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (10): : 956 - 965
  • [19] CFD approach for simulation of API release from solid dosage formulations
    Walsh, Jordan P.
    Ghadiri, Mahdi
    Shirazian, Saeed
    JOURNAL OF MOLECULAR LIQUIDS, 2020, 317 (317)
  • [20] Processing challenges with solid dosage formulations containing vitamin E TPGS
    Pandey, Preetanshu
    Sinko, Patrick D.
    Bindra, Dilbir S.
    Hamey, Rhye
    Gour, Shruti
    Vema-Varapu, Chandra
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (01) : 296 - 304